# Nurix Therapeutics, Inc.: filings

NRIX · Nasdaq · CIK 1549595 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Nov 30

Pages: [Overview](/companies/nrix.md) · [Financials](/companies/nrix/financials.md) · [Filings](/companies/nrix/filings.md) · [Insiders](/companies/nrix/insiders.md)

## Reports and events: 114 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 245, 8-K 79, 144 41, SC 13G/A 25, 3 24, 10-Q 19, SC 13G 15, SCHEDULE 13G/A 15, SCHEDULE 13G 9, 424B5 8, S-8 8, 10-K 6, CORRESP 6, DEF 14A 6, DEFA14A 6, D 5, ARS 4, UPLOAD 4, EFFECT 3, 424B4 2, DRS 2, S-1 2, S-1/A 2, S-3ASR 2, 8-A12B 1, CERT 1, D/A 1, DRS/A 1, DRSLTR 1, FWP 1, POS AM 1, POSASR 1, POS EX 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-13 | 10:21 ET | [10-Q](/filings/0001549595-26-000049.md) | Quarterly report, period 2026-08-31 | 0001549595-26-000049 |
| 2026-10-13 | 10:19 ET | [8-K](/filings/0001549595-26-000048.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001549595-26-000048 |
| 2026-07-09 | 20:12 ET | [10-Q](/filings/0001549595-26-000040.md) | Quarterly report, period 2026-05-31 | 0001549595-26-000040 |
| 2026-07-09 | 20:09 ET | [8-K](/filings/0001549595-26-000038.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001549595-26-000038 |
| 2026-06-11 | 11:06 ET | [8-K](/filings/0001549595-26-000034.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001549595-26-000034 |
| 2026-06-08 | 10:11 ET | [8-K](/filings/0001549595-26-000030.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001549595-26-000030 |
| 2026-05-15 | 20:03 ET | [8-K](/filings/0001549595-26-000028.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001549595-26-000028 |
| 2026-04-08 | 10:03 ET | [10-Q](/filings/0001549595-26-000025.md) | Quarterly report, period 2026-02-28 | 0001549595-26-000025 |
| 2026-04-08 | 10:02 ET | [8-K](/filings/0001549595-26-000024.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001549595-26-000024 |
| 2026-03-27 | 10:03 ET | [DEF 14A](/filings/0001140361-26-011492.md) | Proxy statement, period 2026-05-15 | 0001140361-26-011492 |
| 2026-03-06 | 21:40 ET | [8-K](/filings/0001193125-26-096734.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-096734 |
| 2026-01-28 | 21:09 ET | [10-K](/filings/0001549595-26-000016.md) | Annual report, period 2025-11-30 | 0001549595-26-000016 |
| 2026-01-28 | 21:03 ET | [8-K](/filings/0001549595-26-000013.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001549595-26-000013 |
| 2026-01-12 | 13:34 ET | [8-K](/filings/0001549595-26-000003.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001549595-26-000003 |
| 2025-12-09 | 11:05 ET | [8-K](/filings/0001549595-25-000121.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001549595-25-000121 |
| 2025-11-10 | 12:15 ET | [8-K](/filings/0001549595-25-000117.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001549595-25-000117 |
| 2025-10-22 | 20:58 ET | [8-K](/filings/0001193125-25-246964.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-246964 |
| 2025-10-22 | 13:04 ET | [8-K](/filings/0001549595-25-000115.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001549595-25-000115 |
| 2025-10-09 | 20:04 ET | [10-Q](/filings/0001549595-25-000113.md) | Quarterly report, period 2025-08-31 | 0001549595-25-000113 |
| 2025-10-09 | 20:02 ET | [8-K](/filings/0001549595-25-000112.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001549595-25-000112 |
| 2025-09-03 | 12:06 ET | [8-K](/filings/0001549595-25-000108.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001549595-25-000108 |
| 2025-08-22 | 20:01 ET | [8-K](/filings/0001549595-25-000105.md) | 5.02 Departure or appointment of officers or directors | 0001549595-25-000105 |
| 2025-07-09 | 20:03 ET | [10-Q](/filings/0001549595-25-000095.md) | Quarterly report, period 2025-05-31 | 0001549595-25-000095 |
| 2025-07-09 | 20:02 ET | [8-K](/filings/0001549595-25-000094.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001549595-25-000094 |
| 2025-06-12 | 12:02 ET | [8-K](/filings/0001549595-25-000086.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001549595-25-000086 |
| 2025-05-19 | 20:08 ET | [8-K](/filings/0001549595-25-000067.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001549595-25-000067 |
| 2025-04-08 | 20:06 ET | [10-Q](/filings/0001549595-25-000055.md) | Quarterly report, period 2025-02-28 | 0001549595-25-000055 |
| 2025-04-08 | 20:02 ET | [8-K](/filings/0001549595-25-000053.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001549595-25-000053 |
| 2025-03-28 | 10:03 ET | [DEF 14A](/filings/0001140361-25-010808.md) | Proxy statement, period 2025-05-19 | 0001140361-25-010808 |
| 2025-03-13 | 20:03 ET | [8-K](/filings/0001549595-25-000043.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001549595-25-000043 |
| 2025-01-28 | 21:15 ET | [10-K](/filings/0001549595-25-000016.md) | Annual report, period 2024-11-30 | 0001549595-25-000016 |
| 2025-01-28 | 21:03 ET | [8-K](/filings/0001549595-25-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001549595-25-000014 |
| 2025-01-13 | 12:02 ET | [8-K](/filings/0001549595-25-000005.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001549595-25-000005 |
| 2024-12-10 | 11:54 ET | [8-K](/filings/0001549595-24-000160.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001549595-24-000160 |
| 2024-10-31 | 20:12 ET | [8-K](/filings/0001193125-24-248678.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-248678 |
| 2024-10-16 | 20:41 ET | [8-K](/filings/0001549595-24-000138.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001549595-24-000138 |
| 2024-10-11 | 20:05 ET | [10-Q](/filings/0001549595-24-000131.md) | Quarterly report, period 2024-08-31 | 0001549595-24-000131 |
| 2024-10-11 | 20:02 ET | [8-K](/filings/0001549595-24-000130.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001549595-24-000130 |
| 2024-09-05 | 11:01 ET | [8-K](/filings/0001549595-24-000120.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001549595-24-000120 |
| 2024-07-11 | 20:07 ET | [10-Q](/filings/0001549595-24-000098.md) | Quarterly report, period 2024-05-31 | 0001549595-24-000098 |
| 2024-07-11 | 20:03 ET | [8-K](/filings/0001549595-24-000097.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001549595-24-000097 |
| 2024-06-17 | 11:02 ET | [8-K](/filings/0001549595-24-000086.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001549595-24-000086 |
| 2024-05-21 | 11:06 ET | [8-K](/filings/0001549595-24-000073.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001549595-24-000073 |
| 2024-04-12 | 21:12 ET | [8-K](/filings/0001193125-24-094875.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-094875 |
| 2024-04-10 | 11:06 ET | [10-Q](/filings/0001549595-24-000049.md) | Quarterly report, period 2024-02-29 | 0001549595-24-000049 |
| 2024-04-10 | 11:02 ET | [8-K](/filings/0001549595-24-000048.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001549595-24-000048 |
| 2024-04-09 | 17:17 ET | [8-K](/filings/0001549595-24-000041.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001549595-24-000041 |
| 2024-03-27 | 11:01 ET | [DEF 14A](/filings/0001140361-24-015447.md) | Proxy statement, period 2024-05-20 | 0001140361-24-015447 |
| 2024-03-11 | 11:02 ET | [8-K](/filings/0001549595-24-000038.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001549595-24-000038 |
| 2024-02-15 | 21:04 ET | [10-K](/filings/0001549595-24-000025.md) | Annual report, period 2023-11-30 | 0001549595-24-000025 |

Page 1 of 3. [Older](/companies/nrix/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.